Complications and Concurrent Disease Associated With Canine Hyperadrenocorticism

https://doi.org/10.1016/S0195-5616(97)50034-9Get rights and content

In untreated hyperadrenocorticism, clinical problems may result from metastasis of an adrenocortical carcinoma, growth of a pituitary tumor, or complications associated with sustained hypercortisolemia itself, such as hypertension, cardiovascular disease, thromboembolism, glucose intolerance, and increased susceptibility to infection. This article discusses the origin, diagnosis, and treatment of the many complications associated with hyperadrenocorticism.

References (0)

Cited by (40)

  • Clinical and microbiological characterization of subclinical bacteriuria and sporadic bacterial cystitis in dogs with spontaneous hypercortisolism

    2021, Comparative Immunology, Microbiology and Infectious Diseases
    Citation Excerpt :

    Previous studies reported that approximately 39–50% of dogs with spontaneous HC or those under continuous use of GC presented concomitant UTI [5–7]. This UTI predisposition might be related to the inhibition of the neutrophils and macrophages migration to the affected areas induced by glucocorticoids [8]. Typical UTI clinical signs include pollakiuria, dysuria, and hematuria; however, many dogs with HC may remain asymptomatic possibly due to cortisol anti-inflammatory effects [1], as well as due to polyuria secondary to HC-induced ADH inhibition [1] that can make it difficult for tutors to detect clinical signs, and by these ways classified as presenting subclinical bacteriuria (SB) [9].

  • Concurrent hyperadrenocorticism and diabetes mellitus in dogs

    2017, Research in Veterinary Science
    Citation Excerpt :

    The incidence of DM in felines with HAC is approximately 80–90% (Niessen et al., 2013; Valentin et al., 2014). Some authors sustain that approximately 16.6–22% of dogs with HAC present concurrent DM (Gomes Pöppl et al., 2016; Peterson et al., 1981), while others affirm that this association is around 5–10% (Ishino et al., 2010; Nichols, 1997) and that the overvaluation of this prevalence is due to diagnostic errors, as a result of the difficulty in interpreting the tests for HAC in special cases such as dogs with uncontrolled DM (Behrend, 2015; Kaplan et al., 1995). In the present study, we observed that the concurrence of HAC and DM in the city of Buenos Aires, during 2011 and 2015, was 13.61%, which was close to the value we had previously reported (Miceli et al., 2012).

  • Tumors of the Endocrine System

    2012, Withrow and MacEwen's Small Animal Clinical Oncology: Fifth Edition
  • Aortic thrombosis in dogs: Presentation, therapy, and outcome in 26 cases

    2012, Journal of Veterinary Cardiology
    Citation Excerpt :

    Antithrombin levels were found to be decreased in 47% of dogs in this study when it was measured. Humans with hyperadrenocorticism have been reported to have the potential for both hypercoagulable and hypofibrinolytic states that are thought to contribute to a prothrombotic state, and thromboembolism has been a documented occurrence in dogs with hyperadrenocorticism as well.24,27,28 Hypofibrinolysis, hypercoagulability, platelet aggregation promotion, and endothelial dysfunction have been shown to exist to some degree in both hypothyroidism and diabetes mellitus.29–31

  • Cardiovascular effects of systemic diseases

    2008, Manual of Canine and Feline Cardiology
View all citing articles on Scopus
View full text